{"id":789,"date":"2016-05-19T07:25:57","date_gmt":"2016-05-19T12:25:57","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=789"},"modified":"2018-04-23T11:48:56","modified_gmt":"2018-04-23T16:48:56","slug":"fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/","title":{"rendered":"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction"},"content":{"rendered":"

Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement<\/a> regarding the safety of using a number of mental health drugs. According to the statement, Zyprexa, Zyprexa Zydis, Zyprexa Replrevv, and Symbyax may cause patients to develop serious complications, such as facial swelling, swelling in the lymph glands, and fevers accompanied with a rash. These symptoms are referred to as Drug Reaction with Eosinophilia and Systemic Symptoms, or DRESS.<\/p>\n

A patient experiencing DRESS may first identify a rash on his or her body that begins to spread. Swelling in the face or lymph glands occurs due to a higher-than-average reaction of infection-fighting white blood cells to the situation. This is called eosinophils.<\/p>\n

So far, there have been 23 known reports of patients who have experienced DRESS while taking these drugs, which are olanzapine-based. The first product containing olanzapine was approved by the FDA in\u00a01996. The drug has been prescribed to treat mental health conditions like bipolar disorder and schizophrenia. While Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax are the common names under which olanzapine is sold, there are also generic brands for the drug.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to the statement, Zyprexa, Zyprexa Zydis, Zyprexa Replrevv, and Symbyax may cause patients to develop serious complications, such as facial swelling, swelling in the lymph glands, and fevers accompanied with a rash. […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-789","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"\nFDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction — Illinois Injury and Mass Tort Lawyer Blog — May 19, 2016<\/title>\n<meta name=\"description\" content=\"Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to — May 19, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction — Illinois Injury and Mass Tort Lawyer Blog — May 19, 2016\" \/>\n<meta name=\"twitter:description\" content=\"Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to — May 19, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction — Illinois Injury and Mass Tort Lawyer Blog — May 19, 2016","description":"Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to — May 19, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/","twitter_card":"summary_large_image","twitter_title":"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction — Illinois Injury and Mass Tort Lawyer Blog — May 19, 2016","twitter_description":"Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to — May 19, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/","url":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/","name":"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction — Illinois Injury and Mass Tort Lawyer Blog — May 19, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-05-19T12:25:57+00:00","dateModified":"2018-04-23T16:48:56+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Earlier this month, the U.S. Food and Drug Administration\u00a0made an announcement regarding the safety of using a number of mental health drugs. According to — May 19, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-zyprexa-symbyax-may-cause-dangerous-reaction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Warns that Zyprexa, Symbyax May Cause Dangerous Reaction"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=789"}],"version-history":[{"count":3,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/789\/revisions"}],"predecessor-version":[{"id":2243,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/789\/revisions\/2243"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}